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Abstract
Background: Clinical governance requires health care professionals to improve standards of care
and has resulted in comparison of clinical performance data. The Myocardial Infarction National
Audit Project (a UK cardiology dataset) tabulates its performance. However funnel plots are the
display method of choice for institutional comparison. We aimed to demonstrate that funnel plots
may be derived from MINAP data and allow more meaningful interpretation of data.
Methods: We examined the attainment of National Service Framework standards for all hospitals
(n = 230) and all patients (n = 99,133) in the MINAP database between 1st April 2003 and 31st March
2004. We generated funnel plots (with control limits at 3 sigma) of Door to Needle and Call to
Needle thrombolysis times, and the use of aspirin, beta-blockers and statins post myocardial
infarction.
Results: Only 87,427 patients fulfilled criteria for analysis of the use of secondary prevention drugs
and 15,111 patients for analysis by Door to Needle and Call to Needle times (163 hospitals
achieved the standards for Door to Needle times and 215 were within or above their control
limits). One hundred and sixteen hospitals fell outside the 'within 25%' and 'more than 25%'
standards for Call to Needle times, but 28 were below the lower control limits. Sixteen hospitals
failed to reach the standards for aspirin usage post AMI and 24 remained below the lower control
limits. Thirty hospitals were below the lower CL for beta-blocker usage and 49 outside the
standard. Statin use was comparable.
Conclusion: Funnel plots may be applied to a complex dataset and allow visual comparison of data
derived from multiple health-care units. Variation is readily identified permitting units to appraise
their practices so that effective quality improvement may take place.
Background
Improving the quality of care in the National Health Serv-
ice (NHS) by responding to variations in clinical processes
and outcomes is an imperative required by the United
Kingdom (UK) Government [1]. It has been prompted by
incidents of failure of professional self-regulation, notably
the Bristol and Shipman cases [2,3] and resulted in the
collection of comparative data at all levels of healthcare
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provision. Though methods for using data to respond to
variation are not established, [4] funnel plots are sug-
gested as the display method of choice for institutional
comparison [5].
Funnel plots are based on Statistical Process Control
(SPC), a set of methods for ongoing improvement of sys-
tems, processes and outcomes [6-8]. Recently, compara-
tive performance of UK cardiac surgeons has been
disseminated using these plots [9,10] and they could be
used to study comparative performance measures in other
datasets such as the Myocardial Infarction National Audit
Project (MINAP) registry (a UK cardiology dataset that
characteristically represents its results as performance
tables) [11]. We aimed to demonstrate that funnel plots
may be derived from existing MINAP data and that they
provide more meaningful interpretation of complex data.
Methods
Database
We studied all patients (and all hospitals in England who
manage acute myocardial infarction (AMI)) who were
entered into the MINAP database between 1st April 2003
and 31st March 2004. We tabulated the results of the
MINAP database by the five variables reported in the
MINAP Third Public Report [11], namely: Door to Needle
Time (DTN), Call to Needle Time (CTN), and the use of
aspirin, beta-blockers and HMG-CoA reductase inhibitors
for secondary prevention (that is, drugs that reduce the
risk of further AMIs). For the analysis we included all
patients with an admission diagnosis of definite AMI that
had no justified delay to treatment and received thrombo-
lytic treatment. (Justified delays to treatment included
hypertension, concern over risk of bleeding, delay in
obtaining consent, non-diagnostic initial electrocardio-
grams, cardiac arrest, or insufficient information).
Funnel plots
For each target we generated scatter plots of performance,
as a percentage, against the number of cases reported (the
denominator for the percentage). The mean hospital per-
formance and exact binomial 3 sigma limits were calcu-
lated for all possible values for the number of cases and
used to create a funnel plot using the method described by
Spiegelhalter [11]. MINAP set absolute targets for achieve-
ment and we made funnel charts using 3 sigma limits
around the target and around the mean. Only charts using
a funnel based on the mean are presented (except for
dtn30 for which both sets of limits are shown) as there
was no substantial difference between methods for
thrombolysis measures and for the secondary medication
measures relatively few hospitals fell within the funnel's
limits and many fell above the upper limit when the limits
were set around the target. The absolute targets are also
arbitrary as no one knows what the precise levels should
be for these measures in real practice in the NHS. We also
believe that most clinicians aim to be as good as their col-
leagues rather than seeking to meet a particular externally
set clinical target. The measures used are process rather
than outcome measures. The three funnel plots for use of
secondary prevention medications show variation which
seems related to volume of cases – larger volumes seem to
relate to lower achievement. Is there a systematic reason
why care, or recording of care, is more difficult in larger
units? Although the clinical processes measured do not
vary solely by chance, comparing the variation in results
to chance helps us see where differences are important
enough to investigate. We consider this is a good reason
for showing the results in a scatter as this variability is very
difficult to see in a table.
Special-cause and common-cause variation
When the performance of clinical units is compared, one
might expect process measures to not necessarily display
variability consistent with chance, as there are likely to be
systematic reasons for differences. Variation may be attrib-
utable to either 'common-cause variation' or 'special-
cause variation'. We considered that units displayed 'spe-
cial cause variation' when their performance fell beyond
the limit lines of the funnel plot and that they were
located there due to the presence of systematic influences
[12].
We considered that units displayed 'common-cause varia-
tion' when their performance fell within the limit lines of
the funnel plot indicating that their performance varied
only by an amount consistent with random chance. It
would be expected that the patient factors that influence
the clinical decisions being measured at unit level would
be likely to present randomly to units across the UK and
that decision-making might therefore be expected to vary
by this amount if no systematic differences in the deci-
sion-making processes and thresholds exists between
units.
Common-cause variation (because it is linked to chance),
is greatest when numbers of patients are small (left of fun-
nel plot) and reduces as numbers of patients per unit
increases. While being within the funnel plot's limits does
not exclude the possibility of more moderate or opposing
systematic influences being present, the most likely expla-
nation for the variation seen for units within the limit
lines of the funnel plot is that it results from common-
cause variation. This is background noise that is a feature
of the process itself [13]. It may reflect local variances in
hospital-specific practices and policies such as day-to-day
variations in staffing levels or marginal differences in tran-
sit times (for geographical reasons).BMC Cardiovascular Disorders 2006, 6:34 http://www.biomedcentral.com/1471-2261/6/34
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Comparison
We used the Planning and Performance Framework
(2003–6) standards to define achievement as those
'reaching the goal', 'within 25% of the goal' and 'more
than 25% from the goal'. Attainment of these standards is
used in the derivation of performance tables for the
annual MINAP reports. Achievement goals are different
for thrombolytic treatment (DTN and CTN) and second-
ary prevention (aspirin, beta-blockers and HMG-CoA
reductase inhibitors). For the DTN standard, 75% of
patients were required to receive thrombolytic treatment
within 30 minutes whereas for the CTN standard 48% of
patients were required to receive thrombolytic treatment
within 60 minutes in 2003–4. The standard for secondary
prevention treatments was that 80% of patients dis-
charged from hospital should receive aspirin, beta-block-
ers and HMG-CoA reductase inhibitors. We used these
definitions to generate results for our dataset and to com-
pare them with the number of hospitals above, below or
within the control limits as calculated by our funnel plots.
The numbers of hospitals that had fewer than 20 cases,
but met the MINAP analysis criteria were also recorded.
Results
There were 99,133 patients in the MINAP database, which
covered between 225 and 230 hospitals for the five varia-
bles. Only 87,427 fulfilled the inclusion criteria for analy-
sis of the use of secondary prevention drugs (final
diagnosis of AMI) and 15,111 for analysis by DTN and
CTN times (as only ST-Elevation AMI patients are eligible
for thrombolysis). For the five MINAP output variables
(CTN, DTN, use of aspirin, beta-blockers and HMG-CoA
reductase inhibitors) between 8 and 25 hospitals were
excluded from the MINAP performance tabulation, but
were included in the SPC analysis.
The funnel plots for thrombolytic treatment goals demon-
strated a wide dispersion of process data and nearly as
many hospitals were above the control limits as below
(figures 1 and 2). The funnel plots for secondary preven-
tion showed a similar amount of dispersion beyond con-
trol limits (figures 3, 4 and 5).
For DTN, we identified 163 hospitals that achieved the
performance standards, but 215 hospitals were found
within the funnel or above the upper control limit (table
1). For CTN, 116 hospitals fell outside the 'within 25%'
and 'more than 25%' performance standards, whereas
using SPC we only identified 28 below the lower control
limit.
When we compared the numbers of hospitals achieving
performance standards for the medication targets with
funnel plot depictions, we found that despite them being
'within 25%' of their attainment standards, many hospi-
tals were below the lower control limits. Sixteen hospitals
failed to reach the performance standards for aspirin
usage post AMI, but when analysed by SPC these 16 and a
further 8 hospitals remained below the lower control
limit. For beta-blockers usage, 30 hospitals were below
the lower control limit and 49 outside the achievement
standards. HMG-CoA reductase inhibitor use was compa-
rable from SPC analysis (31 below the lower control
limit) and performance standards (and 26 not achieving
the performance standard).
For the five MINAP output variables, between 26 and 43
hospitals where found to lie above their respective upper
control limits (table 1).
Discussion
Other statistical methods for health-care surveillance exist
[14-16], but funnel plots offer readily interpretable plots
of multiple unit comparisons that allow for sample size,
using a scale that is intuitive for clinicians to use. Funnel
plots permit SPC assessment to be applied to a complex
dataset using crude (not case-mix adjusted) comparison
of outcome data derived from multiple healthcare units.
The analysis is not restricted by number of cases per unit.
Common-cause and special-cause variation can be readily
visualised (through the identification of units outside of
the funnel) and it permits each unit to appraise their local
practices e.g. low use of statins at discharge.
Special-cause and common-cause variation
Special-cause variation was identified in the MINAP fun-
nel plots. The thrombolysis funnel plots revealed a wide
dispersion of data suggesting a single consistent process of
care was not occurring across the hospitals, but that mul-
tiple processes were producing the measured outcome.
This is not surprising as the call to door process (carried
out by ambulance services) is a different process to door
to needle (carried out by hospitals). Though the second-
ary prevention funnel plots conformed to the control lim-
its, outliers were readily identified below the lower
control limits suggesting under achievement. A number of
hospitals lay more than 3 sigma above the mean signify-
ing either good clinical practice or favourable systematic
biases in the collection and submission of data. Just as
areas for improvement can be identified in some units,
unit processes that have contributed to high attainment of
National targets can be used as examples of 'good practice'
that might be reproduced in other hospitals. Where the
number of cases is smaller than expected (perhaps
because of unusually high excepting of patients from the
measure), the relative position along the x axis compared
with other similar units is useful, although MINAP use
codes rather than hospital names as identifiers.BMC Cardiovascular Disorders 2006, 6:34 http://www.biomedcentral.com/1471-2261/6/34
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We noted that for some hospitals, high numbers of
patients were receiving secondary prevention medications
but this did not correspond to the numbers of patients
receiving thrombolysis. This is because analysis for sec-
ondary prevention is performed for all patients having
AMI (whether ST segment elevation, non-ST elevation,
threatened AMI or unconfirmed AMI). Alternatively,
some units may have focused resources on one target (e.g.
by provision of a 24 hour thrombolysis-nurse service) in
Funnel plot for percentage of patients thrombolysed within  60 minutes of calling for help (CTN 60) Figure 2
Funnel plot for percentage of patients thrombolysed within 
60 minutes of calling for help (CTN 60). Data abstracted 
from the MINAP Third Public Report.[11] CTN = call to 
needle time, LCL = lower control limit, UCL = upper control 
limit, target = National Service Framework for coronary 
heart disease goal of 48%. Mean and target performance 
coincide at 48%.
Table 1: Comparison of the numbers of hospitals achieving NSF goals and the number inside and outside 3 sigma limits.
DTN CTN Aspirin Beta-blocker Statin
Analysis by attainment of NSF targets
Reaching the goal 163 102 191 151 180
Within 25% of the goal 51 0 16 46 24
More than 25% from the goal 8 116 0 3 2
Less than 20 cases 8 12 20 25 20
Total 230 230 227 225 226
Analysis by funnel plot
Above UCL 33 32 40 43 34
Within limits 182 170 187 152 164
Below LCL 15 28* 24 30 31
Total 230 230 227 225 226
Discrepancy between table and funnel plot assessment of performance
Within target and below LCL 0 0 8 0 5
Within 25% of target but below LCL 8 28* 16 27 24
Beyond 25% of target and below LCL 7 0 0 3 2
Within target but above UCL 27 32 37 44 35
Total discrepancy 42 60 61 74 66
DTN = door to needle time, CTN = call to needle time, Statin = HMG-CoA reductase inhibitor, NSF = National Service Framework for Coronary 
Heart Disease.
*The 'within 25% of target' did not apply to CTN 60. In total, 108 hospitals were above the 48% target and 122 below it, of which 28 were also 
below the LCL.
Funnel plot for percentage of patients thrombolysed within  30 minutes of arriving in hospital (DTN 30) Figure 1
Funnel plot for percentage of patients thrombolysed within 
30 minutes of arriving in hospital (DTN 30). Data abstracted 
from the MINAP Third Public Report.[11] DTN = door to 
needle time, LCL = lower control limit, UCL = upper control 
limit, target = National Service Framework for coronary 
heart disease goal of 75%. Funnel plot with control limits for 
both mean performance and target performance. In this case 
the number of hospitals identified is similar.BMC Cardiovascular Disorders 2006, 6:34 http://www.biomedcentral.com/1471-2261/6/34
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contrast with a second unit focussing on an alternate tar-
get (e.g. by provision and adherence to an acute coronary
syndrome care pathway). Other explanations include
local variations in case-mix as might result from alternate
definition of AMI and availability, use and types of cardiac
enzyme markers [17].
The funnel plots for use of secondary prevention medica-
tions show variation which is related to volume of cases
(larger volumes correspond to lower achievement). This
may be because the recording of care, might be more dif-
ficult in larger hospitals and/or the denominators for
some may be incorrect (some hospitals may have
included patients who wouldn't have qualified clinically
for secondary prevention drugs). If the funnel plots were
labelled with the hospitals' names, each could then check
they have denominators of the size expected.
Performance tabulation
As expected, there was a discrepancy in counts across the
hospitals between SPC methodology and performance
tabulation [18]. Up to a third of counts may be scored dif-
ferently when SPC methodology is used in preference to
performance tabulation. In part, this is due to the con-
struction of control limits around mean performance
rather than the absolute performance target. It also reflects
the ability of SPC to include all hospitals in the analysis
and to more precisely demonstrate evidence of perform-
ance based on sample size. Small hospitals are subject to
greater sampling error in estimates of performance and an
observed failure to meet a performance standard may
occur when appropriate procedures are being followed (if
by chance the small numbers of patients being treated had
an unusual profile). The lack of an upper limit in the per-
formance table contributes between half and two thirds of
the discrepancy.
Performance tables polarise results. They create a state of
'sanctuary' in hospitals above the cut-off and a state of
'alarm' in those below it. Special-cause variation may be
overlooked because results are not considered in the con-
text of control limits (that may be used as a guide to when
Funnel plot for percentage of patients receiving a HMG-CoA  reductase inhibitor as secondary prevention medication on  discharge from hospital Figure 5
Funnel plot for percentage of patients receiving a HMG-CoA 
reductase inhibitor as secondary prevention medication on 
discharge from hospital. Data abstracted from the MINAP 
Third Public Report.[11] Statin = HMG-CoA reductase inhib-
itor, LCL = lower control limit, UCL = upper control limit, 
target = National Service Framework for coronary heart dis-
ease goal of 80%, target 25% = more than 25% from the goal.
Funnel plot for percentage of patients receiving aspirin as  secondary prevention medication on discharge from hospital Figure 3
Funnel plot for percentage of patients receiving aspirin as 
secondary prevention medication on discharge from hospital. 
Data abstracted from the MINAP Third Public Report.[11] 
LCL = lower control limit, UCL = upper control limit, target 
= National Service Framework for coronary heart disease 
goal of 80%, target 25% = more than 25% from the goal.
Funnel plot for percentage of patients receiving a beta  blocker as secondary prevention medication on discharge  from hospital Figure 4
Funnel plot for percentage of patients receiving a beta 
blocker as secondary prevention medication on discharge 
from hospital. Data abstracted from the MINAP Third Public 
Report.[11] LCL = lower control limit, UCL = upper control 
limit, target = National Service Framework for coronary 
heart disease goal of 80%, target 25% = more than 25% from 
the goal.BMC Cardiovascular Disorders 2006, 6:34 http://www.biomedcentral.com/1471-2261/6/34
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it is uneconomic to look for assignable causes). SPC
allows those hospitals with smaller numbers of patients to
have a greater acceptable variance avoiding the need for
them to be excluded. Moreover, the use of categories of
performance (e.g. the 'within 25% category') may lead to
inaccurate hospital performance estimates. They may
overestimate performance because despite some hospitals
being 'within 25%' of their attainment goals, many were
found to be below the lower control limits. This occurs in
hospitals with a greater number of cases (figure 4 and 5)
and highlights the fact that the use of pre-set targets (that
are independent of case volume) is problematic.
Because performance tables overlook special-cause varia-
tion, they may misdirect attention to less important com-
mon-cause variation. The secondary prevention
tabulation of the performance standards suggests near
universal compliance with the targets, which although
reassuring, may incline hospitals towards thinking no fur-
ther action is needed. It may also mask excessive treat-
ment of some patients (e.g. the elderly, for which the
evidence base is less convincing). Funnel plots identify
those hospitals that are under performing and visually
suggest that improvements may still be made in ade-
quately performing hospitals. Multi-level modelling
would enable a unit's progress to be plotted over time and
identify those hospitals that are 'coasting' at just above the
target [19]. Although the clinical processes measured do
not vary solely by chance, comparing the variation in
results to chance helps us see where differences are impor-
tant enough to investigate. We consider this is a good rea-
son for showing the results in a scatter as this variability is
difficult to see in a table.
Limitations of SPC
Like all performance measurement and analysis methods,
SPC funnel charts may produce both false negative and
positive results. Performing within limits does not guaran-
tee that a unit may not be underperforming though this
may either be too slight to detect or masked by other fac-
tors. Being outside a control limit is not always abnormal
(special cause) either. Of the 230 hospitals, 2 or 3 may be
outside the 3 sigma (99.8%) limits by chance alone.
Despite such false negative and positive results, it is
important to remember that truly detecting a 'special
cause' encourages further investigation at the level of the
individual hospital (and not missing this opportunity).
Similarly funnel plots help prevent investigation of an
outcome resulting from a common-cause as if it were a
special-cause.
Improvement activity
Credibly using data to raise local awareness among health
care staff of the need for improvements in processes is
vital when there is under-achievement in clinical perform-
ance. In the event that units believe the implications of the
funnel plots to be clinically invalid, then attention might
rather focus on possible anomalies in the process of data-
gathering and reporting at that unit as compared to oth-
ers.
Conclusion
The Myocardial Infarction National Audit Project is at the
forefront of the clinically-led registries, with the collection
of consistent, comprehensive and accurate clinical infor-
mation about a specific group of patients. It represents the
most robustly collected data of its type and as such is a key
pioneering project in which different methods of analysis
can be tested. We have demonstrated that the extensive
clinical output data may be visualised for direct compari-
son across multiple units using funnel plots. They avoid
the worst of the polarisation of results associated with the
'ticks and crosses' in performance tables and allow the
identification of potential areas of achievement that war-
rant further attention to permit continuing improvement
in the quality of care offered to patients. The routine pub-
lication of funnel plots summarising cardiology perform-
ance attainments will encourage the understanding,
reflection, processes analysis and subsequent improve-
ments in health-care at all levels of policy, planning and
actual delivery.
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